Regular visits to the dentist may do more than just brighten your smile, they may also lead to fewer hospital visits and trips to the emergency room, as well as lower your medical costs. These are the conclusions from a three-year Cigna dental study that looked at the potential benefits of treated periodontal (gum) disease. The findings were recently presented at the International Association for Dental Research (IADR) conference in Seattle. IADR is a non-profit organization dedicated to advancing research and increasing knowledge to improve oral health worldwide.
“Advancing our understanding of how treatment for gum disease can affect overall health may help lead to the creation of evidence-based treatment standards that could benefit millions of people and simultaneously help reduce medical costs,” said Dr. Robert Genco, a member of Cigna's Dental Clinical Advisory Panel.
According to the Centers for Disease Control and Prevention (CDC), periodontal disease and tooth decay are the two biggest threats to dental health and are mostly seen in adults. Periodontal diseases are infections of the gums and bone that surround and support the teeth. Half of Americans aged 30 or older – 64.7 million people – have periodontitis, the more advanced form of periodontal disease.
Cigna’s study looked at periodontal patients from 2009 through 2011. On average, patients who received gum disease treatment had better outcomes than patients without treatment. Hospital admission rates were 149 per thousand (67%) lower, emergency room visits were 100 per thousand (54%) lower, and medical costs were $1,020 per year (28%) lower.“These results suggest that treating gum disease has benefits beyond better oral health and may also help to control medical costs for some patients,” said Clay Hedlund D.D.S., Cigna's dental director. “We are pleased to be part of the dental community’s ongoing research into the links between good oral health and good overall health.”
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV